Is Exenatide in shortage right now?

No. FDA does not currently list Exenatide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

9 companies have marketed Exenatide in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Exenatide cost?

The typical pharmacy pays about $300.17 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

Market view

exenatide

27 marketed package NDCs · 9 active manufacturers

Most dispensed: 250 ug/mL · Injection · #1 cartridge/carton / 2.4 ml in 1 cartridge · 250 ug/mL · Injection · #1 cartridge/carton / 1.2 ml in 1 cartridge

All forms Powder (23)Injection (4)

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. The brand price has held steady around $510.68 per mL over the past year. Generic versions run $300.17 per mL — 1.7× cheaper.

Price range and competition

RSS: changes for this drug

priced separately — they are not the same market

Brand-name products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

Latest · Aug 2025 — typical price $510.68 · middle half $425.39–$595.97 · full range $340.10–$681.26 · 2 products · 9 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per mLⓘSource: CMS NADAC

ⓘ How this was built

Data sources

CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
CMS Federal Upper Limit files (weighted AMP)
FDA NDC Directory (openFDA) — maker roster

Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Same drug class

Other molecules FDA puts in GLP-1 Receptor Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Exenatide in shortage right now?: No. FDA does not currently list Exenatide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Exenatide?: 9 companies have marketed Exenatide in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Exenatide cost?: The typical pharmacy pays about $300.17 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.